Cyprus & World News

Medochemie finalist in European Business Awards

16 January, 2014

Leading Cyprus-based pharmaceuticals company Medochemie Ltd.  has been named as one of the final 100 businesses and Ruban d’Honneur recipients in the 2013/2014 European Business Awards sponsored by RSM international.

Selected as one of ten finalists in The Imports/Exports Award will now go on to compete in the third and final round of judging resulting in ten overall category winners to be announced at a Gala Event on 27 May in Athens.
The European Business Awards is an independent awards programme designed to recognise and promote excellence, best practice and innovation in the European business community.
The 100 Ruban d’Honneur recipients were chosen from 375 National Champions by an esteemed panel of judges made up of European business and political leaders, academics and entrepreneurs. The judges will now undertake a face-to-face interview with Medochemie Ltd and all the other 99 successful Ruban d’Honneur recipients in order to decide on the overall category winners.
Yiannakis Mouzouris – Area Manager of CEE/CIS said: “We are extremely proud to reach the Ruban d’Honneur stage of the European Business Awards and to represent Cyprus. The European Business Awards is widely recognised as the showcase for Europe’s most dynamic companies and we are now looking forward to describing to the judges in more detail how we are achieving business success.”
Medochemie is an international pharmaceutical manufacturing company with a presence in over 100 countries worldwide. The driving force behind Medochemie is the 1250 talented, quality-focused employees who are based in Cyprus and in 19 offices around the world. With 9 state-of-the-art Manufacturing sites in Cyprus, 1 in the Netherlands and 1 in Vietnam Medochemie develops, markets and manufactures drugs in over 10 categories and provide pharmaceuticals to over 300 million people globally. Medochemie has 3800 marketing authorizations in 630 different product combinations. Medochemie is a member of the European Generics Association (EGA).
Adrian Tripp, CEO of the European Business Awards says, “These businesses are shining examples of European business success and our judges were extremely impressed by the very high standard this year. Medochemie deserves the very best of luck in the highly competitive final round.”
The European Business Awards connect the best in Europe across borders, business size and sector and celebrate excellence, innovation, entrepreneurship and best practice. For more information, please visit .